Products

STAR Apollo Mapping System
Rhythm AI Ltd
Cardiology AI
The STAR Apollo Mapping System by Rhythm AI Ltd is an AI-driven medical device that transforms atrial fibrillation (AF) treatment by providing real-time data analysis from existing electrophysiology systems. It uses sophisticated AI algorithms to identify repetitive arrhythmia patterns and early sites of activation, enabling highly personalized treatment plans for physicians.

See all 1 product →

About Rhythm AI

Rhythm AI is a medical technology company that specializes in developing AI-driven software for the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation (AFib). Their flagship product, the STAR Apollo™ Mapping Software, is designed to optimize AF procedures. The company’s technology aims to enhance atrial fibrillation treatment through innovative data analysis systems and is compatible with widely used 3D mapping platforms like Abbott’s EnSite and Johnson & Johnson’s CARTO 3.

For physicians, Rhythm AI’s solutions offer advanced AI to identify specific regions of the heart affected by AFib, aiding in electrophysiology and catheter ablation procedures. The goal is to provide clinical decision support and improve outcomes for patients undergoing arrhythmia treatment. Recent developments include FDA clearance for their new STAR Apollo™ Mapping System, which is expected to accelerate its U.S. rollout and expand physician access. The company emphasizes its role in digital health and healthcare analytics, aiming to be a comprehensive solution for healthcare providers in electrophysiology.

Focus Areas

Atrial Fibrillation (AF) treatment cardiac arrhythmias 3D cardiac mapping real-time data analysis electrophysiology personalized treatment plans AI-driven algorithms

Business Intelligence

TechnologyAI-driven algorithms, novel computer algorithms, real-time data analysis from existing electrophysiology systems (e.g., Abbott's EnSite X EP System, Johnson & Johnson's CARTO 3 Mapping System), laptop computer based mapping algorithm.

What Physicians Need to Know

Specialization in Atrial Fibrillation (AF) Treatment
Rhythm AI specializes in leveraging artificial intelligence to enhance the detection, mapping, and personalized therapy for Atrial Fibrillation, the most common arrhythmia globally. Their STAR Apollo™ Mapping Software is FDA-cleared and specifically designed to uncover the sources of AF by analyzing electrical signals, providing patient-specific insights to guide catheter ablation strategies.
Advanced Cardiac Arrhythmia Management
Beyond AF, Rhythm AI's technology, including AI-augmented analysis of ECG and wearable sensor data, improves the efficiency and reach of arrhythmia detection and screening. Their AI-driven mapping techniques offer patient-specific insights for more targeted and effective treatment strategies.
3D Cardiac Mapping and Real-time Data Analysis
The STAR Apollo™ Mapping Software provides precise, patient-specific maps by identifying sources of activation based on electrophysiological principles. It leverages intraprocedural data from standard mapping catheters to offer unique insights after each acquisition, integrating with existing mapping systems like Abbott's Ensite™ X EP System and Johnson & Johnson CARTO™ 3 Mapping System.
AI-Driven Algorithms and Personalized Treatment Plans
Rhythm AI utilizes proprietary, deterministic AI algorithms rooted in the first principles of electrophysiology to identify Repetitive Patterns of Activation (RPAs) and Early Sites of Activation (ESAs), which are crucial for pinpointing AF drivers. This enables physicians to create personalized treatment plans, potentially disrupting the cycle of AF progression and reducing the risk of procedure-related complications.
Electrophysiology Enhancement
The company's solutions are designed to empower electrophysiologists with advanced tools to locate AF drivers and plan with precision, especially in complex cases where arrhythmias require ablation beyond pulmonary veins.
Physician Tip

For physicians, Rhythm AI's STAR Apollo™ Mapping Software offers a significant advantage by providing precise, patient-specific maps that identify the sources of atrial fibrillation (AF) drivers. This can lead to more targeted ablation strategies, potentially improving rhythm outcomes and reducing the need for repeat procedures. The system integrates seamlessly with existing mapping systems (Abbott Ensite™ X EP System and Johnson & Johnson CARTO™ 3 Mapping System), requiring only a laptop and a data cable, minimizing disruption to current workflows. The AI-driven insights can help preserve healthy atrial tissue and reduce procedure-related complications. For primary care clinicians, RhythmX AI (a related entity) offers an AI-enabled intelligent assistant to summarize patient information, track progress, and provide recommendations for more holistic, patient-centered care, aiming to reduce cognitive burden.

Rhythm AI's STAR Apollo™ Mapping Software is compatible with Abbott's Ensite™ X EP System and Johnson & Johnson CARTO™ 3 Mapping System. RhythmX AI (a related company) integrates with EHR and payer data, and its platform works in concert with existing healthcare systems. Another entity, Rhythm360, offers comprehensive EHR integration with Epic and Cerner. Rhythm Systems also offers an AI Connector that integrates with AI tools like Claude, ChatGPT, Microsoft Copilot, and Google Gemini, allowing access to strategy execution data.

Products by Rhythm AI

1 product in the directory

STAR Apollo Mapping System
Rhythm AI Ltd
Cardiology AI
The STAR Apollo Mapping System by Rhythm AI Ltd is an AI-driven medical device that transforms atrial fibrillation (AF) treatment by providing real-time data analysis from existing electrophysiology systems. It uses sophisticated AI algorithms to identify repetitive arrhythmia patterns and early sites of activation, enabling highly personalized treatment plans for physicians.

What the Web Says

Rhythm AI, a company focused on AI-powered solutions for healthcare, generally receives mixed to positive reviews. Product reviews often highlight its potential for improving operational efficiency and patient care, particularly in areas like hospital flow and resource management. Employer reviews, while less numerous, suggest a positive work environment with opportunities for growth, though some indicate challenges common to growing tech companies.

Overall: Mixed

Strengths

  • Potential for significant improvements in hospital operational efficiency and patient flow.
  • AI-driven insights can optimize resource allocation and reduce wait times.
  • Innovative technology addressing critical healthcare challenges.
  • Positive feedback on company culture and growth opportunities from employees.
  • Focus on data-driven decision making in healthcare.
  • Potential to enhance patient experience and outcomes.

Limitations

  • Limited number of publicly available detailed product reviews from major platforms like G2 or Capterra.
  • Specific implementation challenges or integration complexities are not widely discussed.
  • As an AI solution, potential concerns about data privacy and security may arise (though not explicitly stated in reviews).
  • Reliance on accurate and comprehensive data for effective AI performance.
  • Potential for a steep learning curve for healthcare staff adopting new AI tools.
  • Specific pricing or ROI details are not readily available in public reviews.

Based on reviews from: Glassdoor, LinkedIn (employee posts/profiles), Healthcare IT news articles and industry analyses, Company website (for product descriptions and claims), General tech and AI industry discussions (for similar product categories)

Last updated: 2026-10-25

Videos

News, demos, and interviews about Rhythm AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Rhythm AI →

View all on YouTube

Press & Coverage

Innovations in Pharmaceutical Technology
RHYTHM AI announces FDA clearance of the commercial release version of STAR Apollo Mapping System
RHYTHM AI Ltd received US FDA 510k clearance for the commercial launch version of its STAR Apollo Mapping System, which optimizes Atrial Fibrillation (AF) treatment with real-time data analysis. The company also reported successful first-in-human cases using the new system.
2024-09
pharmaphorum
FDA clears RHYTHM AI's new algorithm for atrial fibrillation
UK digital health company RHYTHM AI has received FDA approval for a new version of its algorithm designed to map areas of the heart affected by atrial fibrillation (AFib), which will be commercially rolled out. The algorithm aims to support AFib patients who no longer respond to medication.
2024-09
Investing.com
Rhythm AI secures FDA clearance for STAR Apollo mapping system By Investing.com
Rhythm AI Ltd. announced FDA 510(k) clearance for its STAR Apollo Mapping System, now compatible with Johnson & Johnson MedTech's CARTO 3 Mapping System. The UK-based company plans a limited market release in the US in early 2026 for its system, which optimizes atrial fibrillation procedures.
2026-01
EINPresswire.com
Rhythm Systems Unveils Rhythm Intelligence™: AI-Powered Strategic Execution
Rhythm Systems launched Rhythm Intelligence™ (RI), an AI-powered platform that enhances strategic planning and execution for high-performing teams by integrating OpenAI with their proven methodology and real-world insights. RI is designed to help mid-market businesses execute faster and achieve their goals.
2025-03
Healthcare IT News
Get Well and RhythmX AI merge patient engagement and precision medicine
Get Well and RhythmX AI, both part of SymphonyAI Group, are merging to form GW RhythmX, an AI-driven personalized care platform. This new venture will use artificial intelligence to improve health system operations and patient outcomes by uniting clinical, financial, payer, and social data.
2025-11
Signalbase
RhythmX AI Secures $50 Million in Funding for Revolutionary Health AI Platform
RhythmX AI, a health AI company focused on primary care, raised $50 million in funding from its parent company, SAIGroup. This investment will support the development of its platform, which aims to deliver hyper-personalized, whole-person patient care by enhancing AI algorithms for tailored treatments.
2024-10
Fierce Healthcare
Presbyterian Healthcare Services taps RhythmX AI to roll out gen AI copilots for primary care
Presbyterian Healthcare Services is partnering with RhythmX AI to deploy generative AI copilots for primary care clinicians, aiming to modernize decision-making with AI-powered information. The technology offers patient-specific prescriptive actions and recommendations based on extensive longitudinal data.
2024-11
PubMed Central (PMC)
Editorial: Artificial intelligence in cardiac rhythmology - PMC - NIH
This editorial discusses the transformative role of Artificial Intelligence (AI) in medicine, particularly in cardiac rhythmology, highlighting its potential to improve clinical practice and patient outcomes. The integration of AI in ECG reporting is shown to allow quicker and more accurate interpretations, enhancing patient care.
2024-08

Frequently Asked Questions

Rhythm AI focuses on enhancing the precision and effectiveness of AF treatment and other cardiac arrhythmias by leveraging AI-driven algorithms and 3D cardiac mapping. The technology aims to provide electrophysiologists with real-time data analysis to better understand and target arrhythmogenic substrates, potentially leading to improved patient outcomes and reduced recurrence rates.
Rhythm AI's approach integrates advanced AI-driven algorithms with 3D cardiac mapping to offer more sophisticated real-time data analysis than traditional systems. This allows for a more dynamic and comprehensive understanding of cardiac electrical activity during procedures, enabling electrophysiologists to make more informed decisions and personalize treatment strategies.
Rhythm AI offers solutions that likely include AI-powered cardiac mapping platforms and real-time analytical tools designed for electrophysiology labs. These products aim to assist physicians in identifying and ablating cardiac arrhythmias more accurately by providing detailed, actionable insights derived from complex cardiac data.
Rhythm AI is committed to adhering to all relevant medical device regulations and compliance standards to ensure the safety and efficacy of its AI-driven algorithms and products. The company likely follows rigorous testing, validation, and submission processes to obtain necessary regulatory approvals from bodies like the FDA or CE Mark.
While specific pricing models would require direct inquiry with Rhythm AI, they typically involve either per-procedure fees, subscription models, or capital equipment purchases. Rhythm AI is expected to provide comprehensive support and training programs to healthcare providers, ensuring seamless integration and optimal utilization of their technologies within clinical workflows.
Rhythm AI has established partnerships with leading medical institutions and technology providers to further its research and development in cardiac electrophysiology. The company's long-term vision is to revolutionize AF treatment and arrhythmia management through continuous innovation in AI and cardiac mapping, aiming for sustained growth and impact in the healthcare sector.
Rhythm AI's personalized treatment plans, powered by advanced AI algorithms, aim to improve patient outcomes by providing electrophysiologists with highly specific and actionable insights into each patient's unique cardiac anatomy and arrhythmia characteristics. This tailored approach is designed to increase the success rate of ablation procedures, reduce recurrence, and minimize complications, ultimately leading to better long-term health for patients.

Related Companies

Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]

Meril Life Sciences is an Indian multinational medical device company dedicated to the innovation, design, and development of clinically relevant and state-of-the-art devices. The company focuses on alleviating human suffering and improving the quality of life through advanced healthcare solutions. Meril’s extensive product portfolio spans various medical fields, including vascular intervention, orthopedic implants, robotics, endosurgery, […]

Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]

Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]

Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.